• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Biotech

International Stem Cell Corporation to Present at Two Upcoming Investor Conferences
CARLSBAD, CA--(Marketwired - May 15, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company...(more)
International Stem Cell Corporation  
May 15, 2013 08:30 ET
 

 

Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy
NEW YORK, NY--(Marketwired - May 15, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has had its living cell encapsulation or "Cell-in-a-Box" technology tested again and again, and each time it has proven...(more)
Nuvilex, Inc.  
May 15, 2013 08:30 ET
 

 

Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights
SEATTLE, WA--(Marketwired - May 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced its first quarter 2013 financial results and corporate developments....(more)
Atossa Genetics, Inc.  
May 15, 2013 08:30 ET
 

 

Calyx Announces Commercial Launch of Higher Yielding Variety of Resonance(R) Carinata
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 15, 2013) - Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is pleased to announce the commercial launch of an improved variety of Resonance...(more)
Calyx Bio-Ventures Inc.  
May 15, 2013 08:00 ET
 

 

Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence Solution
PORTLAND, OR--(Marketwired - May 15, 2013) - Northwest Analytics, a leader in manufacturing intelligence solutions for process industries, today announced the launch of NWA Focus EMI®, (www...(more)
Northwest Analytics  
May 15, 2013 08:00 ET
 

 

LifeSci Advisors Initiates Coverage of Prothena Corporation
NEW YORK, NY--(Marketwired - May 15, 2013) - Recent Elan Spin-Out Is Well Capitalized With $120 Million in Cash Lead...(more)
LifeSci Advisors  
May 15, 2013 08:00 ET
 

 

Innovotech Reports First Quarter 2013 Financial Results
EDMONTON, ALBERTA--(Marketwired - May 15, 2013) - Innovotech Inc. (TSX VENTURE:IOT), an innovator in the field of biofilm product development, today announced its audited financial and...(more)
Innovotech Inc.  
May 15, 2013 08:00 ET
 

 

Bioheart Announces Addition of New Corporate Controller
SUNRISE, FL--(Marketwired - May 15, 2013) - Bioheart, Inc. (OTCQB: BHRT) announced today that Ms. Evelyn Flores will join Bioheart as Corporate Controller. A tenured finance and accounting...(more)
Bioheart, Inc.  
May 15, 2013 07:00 ET
 

 

Cynapsus Therapeutics Publishes White Paper on Apomorphine for 'Off' Periods in Parkinson's Disease and Its Alternative Delivery Development Candidate APL-130277
TORONTO, ONTARIO--(Marketwired - May 15, 2013) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH), a specialty pharmaceutical company developing the only known orally administered...(more)
Cynapsus Therapeutics Inc.  
May 15, 2013 06:00 ET
 

 

Ablynx Announces Q1 2013 Business Update
GHENT, BELGIUM--(Marketwired - May 15, 2013) - Ablynx (EURONEXT BRUSSELS: ABLX), the Belgian-based biopharmaceutical company focused on the discovery and development of Nanobodies® for the...(more)
Ablynx  
May 15, 2013 02:22 ET